Did you know?

Importance Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease.. Objective (1) To determine the prevalence of psoriasis among adults in the US and (2) to evaluate the change in psoriasis prevalence over time since the 2003-2004 National …Aug 14, 2021 · a For patients with worst pruritus NRS greater than 1 at baseline.. b Data from Measure Up 1 and Measure Up 2 studies. 10. EASI 90/100 indicates 90% or greater/100% improvement in Eczema Area and Severity Index; ITT, intention to treat for the main study; NRS, numeric rating scale; OC, observed case; PBO, placebo; UPA, upadacitinib; vIGA-AD 0, Validated Investigator Global Assessment for ... JAMA Dermatology. Neuropathic itch refers to disorders characterized by chronic itching caused by dysfunction or damage to pruriceptors, nerves involved in itch transmission. In these conditions, itch is not triggered by external stimuli (eg, irritants or allergens), but rather arises spontaneously. Neuropathic itch can occur through nerve damage from …Key Points. Question What were the treatment patterns for alopecia areata (AA) in adults in the US from 2015 to 2020?. Findings In this cohort study of 45 483 adults with AA, on the basis of US medical and pharmacy claims data, most common treatments for AA included intralesional, topical, intramuscular, and oral corticosteroids. JAMA Dermatology Hyperpigmentation is a common cutaneous concern in individuals with skin of color, 1 often leading to psychosocial distress. 2 Given the lack of rigorous clinical studies, expert opinion guides accepted treatment algorithms. 23 Aug 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA ... Acta Derm Venereol. 2015;95(7):835 ...JAMA Dermatology. Key Points. Question What is the association of secukinumab with active tuberculosis (TB) development, TB reactivation, and latent tuberculosis infection (LTBI) activation? Findings In this pooled cohort study of 12 319 patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis, spontaneous reporting of new LTBI while …Key Points. Question What is the long-term (up to 108 weeks) efficacy and safety of ixekizumab for pediatric patients with moderate to severe psoriasis?. Findings In this randomized clinical trial of 139 pediatric patients with plaque psoriasis, those who completed treatment with ixekizumab through week 108 achieved improvement in the Psoriasis …JAMA Dermatology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2168-6068.JAMA Dermatology Clinicopathological Challenge Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex Il-Jae Lee, MD; Seok-Kweon Yun, MD, PhD; Kyung-Hwa Nam, MD, PhD Key Points. Question What is the risk of developing inflammatory bowel disease in children and adults with atopic dermatitis (AD)?. Finding This population-based cohort study of …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Eleven women presented with chronic severe pain and/or pruritus of the scalp only without objective physical findings, a condition we term "scalp dysesthesia." Five women described pain, stinging, or burning only; 4 women complained of pain and pruritus; and 2 women reported pruritus only. The patients ranged in age from 36 to 70 years. Eleven women presented with chronic severe pain and/or pruritus of the scalp only without objective physical findings, a condition we term "scalp dysesthesia." Five women described pain, stinging, or burning only; 4 women complained of pain and pruritus; and 2 women reported pruritus only. The patients ranged in age from 36 to 70 years.Key Points. Question What is the efficacJAMA Dermatology. Home New Online Current Issue For Authors. Podc Key Points. Question What is the long-term (up to 108 weeks) efficacy and safety of ixekizumab for pediatric patients with moderate to severe psoriasis?. Findings In this randomized clinical trial of 139 pediatric patients with plaque psoriasis, those who completed treatment with ixekizumab through week 108 achieved improvement in the Psoriasis Area and Severity Index as well as static ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA … Key Points. Question What is the long-term (up t JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA …JAMA Dermatology. Key Points. Question What are the long-term clearance rates of treatments used in patients with actinic keratosis? Findings This systematic review and network meta-analysis included data from 15 randomized clinical trials reporting sustained clearance rates after at least 12 months of treatment as a proxy for long-term efficacy. … JAMA Dermatology Hair loss (alopecia) is categorized as scarri

2023;159 (3):247-248. doi:10.1001/jamadermatol.2022.6162. Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis. Atopic dermatitis (AD) is a …Importance Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease.. Objective (1) To determine the prevalence of psoriasis among adults in the US and (2) to evaluate the change in psoriasis prevalence over time since the 2003-2004 National …Importance Infantile hemangiomas involute to some extent, but they often leave sequelae that may cause disfigurement. Factors determining the risk of permanent sequelae after regression are of crucial importance in treatment decision making. Objectives To describe the sequelae left by infantile hemangiomas after natural involution and to identify clinical …Aug 1, 2022 · Design, Setting, and ParticipantsThis was a multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial (B-SIMPLE4) conducted in 55 clinics (mostly dermatology and pediatric) in the US from September 1, 2020, to July 21, 2021.

JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Dr Micheletti is Images in Dermatology Editor for JAMA Dermatology. Dr Rosenbach is an Editorial Board member of JAMA Dermatology. Dr Shields is an Assistant Section Editor of JAMA Dermatology. Dr Shinkai is Chief Editor of JAMA Dermatology. Dr Mostaghimi is an Associate Editor of JAMA Dermatology. They were not involved in any of the decisions ... …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Corresponding Author: Ruth Ann Vleugels, MD, Departmen. Possible cause: The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information.